Currently, FIHP is recognized as agenetically heterogeneous disease, with approximately 30% of kindreds affected bypathogenic variants in MEN1, CDC73, CASR, and, more recently, GCM2 genes (18). Here, CASR is linked to familial isolated hyperparathyroidism.